Maxim Biomedical, Inc. (Maxim), located in the Rockville, Maryland, was founded in May 2005. Our mission at Maxim is to develop and market in vitro diagnostic (IVD) and Point-of-care (POC) testing solutions that make positive contributions to public health and healthcare worldwide. Customers can opt-in for our customized CRO/CMO services or purchase from our existing line of FDA or CDC approved products. Our urine and oral-based HIV ELISA and Western Blot tests are designed to be safe, cost-effective, and painless, while our blood-based tests offer proven solutions in a traditional format. We believe that by offering both non-blood and traditional blood-based testing solutions for HIV infection and other chronic diseases, we can create more opportunities for better healthcare worldwide.
Who We Are
Since its inception, Maxim has since acquired the Calypte's three product lines for screening and supplemental tests for HIV-1 antibodies. We carry reliable screening and supplemental urine tests for HIV-1 antibodies.
Every Maxim product is manufactured according to U.S. Food and Drug Administration (FDA) Good Manufacturing Practice standards in our 30,000 square foot facility. The company also has U.S. FDA Certificates to Foreign Governments and Certificates of Exportability for our products. Maxim markets its products through a network of national and regional distributors.